Dihydroergotamine + Erythromycin Ethylsuccinate Interaction
Contraindicatedinteraction on record
Description
Coadministration associated with acute ergot toxicity characterized by vasospasm and ischemia of extremities and central nervous system.
Mechanism
CYP3A inhibition increases dihydroergotamine levels
Source: NLP:erythromycin ethylsuccinate